首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Anti-tumor activity of Annona squamosa seeds extract containing annonaceous acetogenin compounds
【24h】

Anti-tumor activity of Annona squamosa seeds extract containing annonaceous acetogenin compounds

机译:含非丙酮生乙酸原化合物的番荔枝番荔枝种子提取物的抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: Seeds of Annona squamosa L. have been used in the south of China as a folk remedy to treat malignant sores (cancer). Aim of the study: To investigate the chemical constituents and the anti-tumor activity of the standardized A. squamosa seeds extract in vitro and in vivo. Materials and methods: Annonaceous acetogenin profiles of the standardized extract were determined by using Fourier transform infrared (FT-IR) and high performance liquid chromatography (HPLC) techniques. The anti-tumor activity of the extract was tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cytotoxicity in vitro and H 22 hepatoma cells transplantation tumor model in vivo. Results: The FT-IR spectroscopy showed the presence of annonaceous acetogenin compounds in the extract. Two major annonaceous acetogenins: 12, 15-cis-squamostatin-A and bullatacin were identified and quantified by HPLC. The seed extract showed significant anti-tumor activity against four human tumor cell lines, especially for MCF-7 (IC 50. 0.25 μg/ml) and Hep G2 (IC 50. 0.36 μg/ml) cells in vitro. The extract inhibited the growth of H 22 tumor cells in mice with a maximum inhibitory rate of 69.55% by oral administration. Conclusion: A. squamosa seed extract showed significant anti-tumor activities against human hepatoma cells in vitro and in vivo, indicating a potential for developing the extract as a novel anti-liver cancer drug.
机译:人类药理学相关性:中国南部已将番荔枝种子(Annona squamosa L.)的种子用作治疗恶性疮(癌)的民间疗法。研究的目的:在体外和体内研究标准化鳞球种子提取物的化学成分和抗肿瘤活性。材料和方法:使用傅立叶变换红外(FT-IR)和高效液相色谱(HPLC)技术确定标准化提取物的非丙酮产乙酸原。提取物的抗肿瘤活性通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑(MTT)的体外细胞毒性和体内H 22肝癌细胞移植肿瘤模型进行测试。结果:FT-IR光谱显示提取物中存在非乙酰丙酮原化合物。 HPLC鉴定并定量了两种主要的非丙酮生乙酸原素:12、15-顺式-静抑素-A和布勒他星。种子提取物显示出对四种人类肿瘤细胞系的显着抗肿瘤活性,特别是对体外的MCF-7(IC 50. 0.25μg/ ml)和Hep G2(IC 50. 0.36μg/ ml)细胞。该提取物通过口服给药以最大抑制率为69.55%抑制小鼠中H 22肿瘤细胞的生长。结论:鳞球菌种子提取物在体外和体内均对人肝癌细胞具有显着的抗肿瘤活性,这表明该提取物具有开发新型抗肝癌药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号